Switzerland takes the top spot in total patent filings per capita to the European Patent Office (EPO). Among Swiss companies, pharmaceutical company Roche leads the number of patent filings for the fourth year in a row while industrial and robotics company ABB recorded the fastest growth.
The EPO received 7,927 applications from the Alpine nation in 2018 – a 7.8% increase from 2017 and the highest level recorded since 2010 according to the agency’s annual report.
This represents 956 requests for patents per million people compared to 884 for the previous year. This was followed by the Netherlands with 416 applications per million inhabitants and Denmark with 411.
In terms of total applications, the United States is the most active with 25% of the total of 174,317 applications followed by Germany (15%) and Japan (13%). Switzerland and China both ranked 5th with 5% of total applications. While China’s patent filings increased by 8.8%, this was the country’s slowest growth in the last five years.
The measurement systems sector accounts for the largest share of patent applications with 10%, followed by medical technologies (9%).
Swiss scene
As for Swiss companies, Roche is the reigning champion for the fourth year in a row with a 1.2% increase to 651 patent filings in 2018. However, robotics and automation specialist ABB recorded a much higher increase in the number of patents (12.4%) with 571. Nestlé came in third among Swiss companies but filed 15.3% less patents than 2017.
Globally, Siemens led corporate filings with nearly 2,500 patents with Huawei coming in a close second. Roche came in 24th globally.
Among universities, the Federal Institutes of Technology in Zurich (ETHZ) and Lausanne (EPFL) took 13th and 14th place respectively.
More
More
Swiss remain top of world innovation ranking
This content was published on
Switzerland is the leading nation for innovation for the seventh year in a row, according to the World Intellectual Property Organization (WIPO).
Have you heard something about Swiss diplomacy that you’d like us to fact check?
Not all information circulating about Switzerland’s foreign relations is accurate or well understood. Tell us what you'd like us to fact check or clarify.
Iran and EU discuss nuclear issues, Russia and the Middle East in Switzerland
This content was published on
After meeting with French, German, and British representatives on Monday, Iran continued its talks with the EU representative in Geneva.
This content was published on
Lucerne-based steelmaker Swiss Steel has confirmed it will cut 130 jobs in Emmenbrücke, despite the emergency aid promised by Switzerland’s parliament.
Swiss SGS and French Bureau Veritas eye $35 billion merger
This content was published on
The Swiss inspection firm SGS has confirmed it is in talks with the French company Bureau Veritas about a potential merger of nearly $35 billion.
European committee raises alarm over police violence in western Switzerland
This content was published on
A Council of Europe committee is concerned about police practices in western Switzerland, citing “allegations of physical mistreatment” against detainees.
WEF: Trump to speak virtually, Zelensky to appear in person
This content was published on
US President-elect Donald Trump will attend this year's annual meeting of the World Economic Forum (WEF) in Davos via video conference. He is scheduled to speak on January 23.
Coop washes its hands of The Body Shop in Switzerland
This content was published on
The Body Shop is facing closure in Switzerland. Retailer Coop is no longer extending the franchise agreement for its cosmetics subsidiary.
Three out of ten Ukrainian refugees in Switzerland have a job
This content was published on
More and more refugees from Ukraine have a job in Switzerland. The employment rate of people with protection status S was just under 30% at the end of 2024.
Swiss private companies invest CHF18 billion in research
This content was published on
In 2023, private companies in Switzerland spent CHF18 billion ($19.7 billion) on their own research and development. This is CHF1.2 billion more than in 2021.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
Switzerland ranked highly for international patents in 2017
This content was published on
Switzerland was the eighth biggest source of international patent applications last year, says the World Intellectual Property Organization (WIPO).
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.